Clinical Trials
Disease States
- Breast Cancer
- Colorectal Cancer
- Gastric Cancer
- Genitourinary Cancer
- Leukemia
- Lung Cancer
- Lymphoma
- Pancreatic Cancer
- Supportive Care and Disease Registries
Leukemia
NCT03801525: Study to Assess the Efficacy and Safety of Ublituximab Plus Umbralisib in Combination with Venetoclax in Subjects with CLL (ULTRA-V)
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT03801525?term=TG+Therapeutics&recrs=a&cond=CLL&draw=1&rank=2
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
NCT04116437: Study of Zanubrutinib (BGB-3111) in Participants with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT04116437?term=Beigene&cond=CLL&draw=2&rank=3
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
[ back to top ]
Lung Cancer
NCT03906071 Phase 3 Study of Siltravatinib Plus Nivolumab vs Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT03906071?term=Mirati&cond=NSCLC&draw=2&rank=1
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
[ back to top ]
Lymphoma
NCT02793583: Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 Alone in Patients with Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT02793583?term=TG+Therapeutics&cond=Follicular+Lymphoma&draw=2&rank=4
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
NCT04116437: Study of Zanubrutinib (BGB-3111) in Participants with Previously Treated Chronic Lymphocytic Lukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT04116437?term=Beigene&cond=CLL&draw=2&rank=3
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
NCT03778073: Study of TG-1501 in Subjects with Relapsed or Refractory Lymphoma
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT03778073?term=TG+Therapeutics&cond=B-cell+Lymphoma&draw=2&rank=3
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
[ back to top ]
[ back to top ]
Supportive Care and Disease Registries
NCT03836105 CemiplimAB Survivorship Epidemiology (CASE)
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT03836105?term=Regeneron&recrs=a&cond=Squamous+Cell+Carcinoma&cntry=US&state=US%3AAL&draw=2&rank=1
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
NCT04180176 A Prospective Clinicogenomic Program (GX41563)
Trial Information:
https://clinicaltrials.gov/ct2/show/NCT04180176?term=NCT04180176&draw=2&rank=1
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
DLS ABRT Trial (BioBank)
Trial Information:
https://www.dls.com/biopharma/
Contact the CCI Research Team for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
[ back to top ]
